KIORA PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
KIORA PHARMACEUTICALS, INC. (KPRX) reported Diluted Shares Outstanding (Weighted Average) of 6.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 6.18M shares, a 54.87% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 4.17M shares, a 1.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 3.92M shares, a 7.17% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 4.36M shares, a 3.48% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 4.10M shares, a 0.51% decline from fiscal 2024.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 4.13M shares, a 666.73% increase from fiscal 2023.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 538.01K shares, a 26.53% decline from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 732.30K shares, a 203.74% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 6.18M shares 10-Q · filed 2026-08-07 | 5.18M shares 10-Q · filed 2026-08-07 | 4.76M shares derived: average of 3 quarters · filed 2026-08-07 | 4.66M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 4.17M shares 10-Q · filed 2026-05-08 | 4.05M shares derived: average of 2 quarters · filed 2026-05-08 | 4.15M shares derived: average of 3 quarters · filed 2026-05-08 | 4.11M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | 3.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 4.14M shares derived: average of 2 quarters · filed 2026-03-25 | 4.09M shares derived: average of 3 quarters · filed 2026-08-07 | 4.10M shares 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | 4.36M shares 10-Q · filed 2025-11-07 | 4.18M shares derived: average of 2 quarters · filed 2026-08-07 | 4.17M shares 10-Q · filed 2025-11-07 | 4.20M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 3.99M shares 10-Q · filed 2026-08-07 | 3.94M shares 10-Q · filed 2026-08-07 | 4.14M shares derived: average of 3 quarters · filed 2026-08-07 | 4.16M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | 4.22M shares 10-Q · filed 2026-05-08 | 4.22M shares derived: average of 2 quarters · filed 2026-05-08 | 4.22M shares derived: average of 3 quarters · filed 2026-05-08 | 4.21M shares derived: average of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 4.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 4.22M shares derived: average of 2 quarters · filed 2026-03-25 | 4.20M shares derived: average of 3 quarters · filed 2026-03-25 | 4.13M shares 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | 4.21M shares 10-Q · filed 2025-11-07 | 4.19M shares derived: average of 2 quarters · filed 2025-11-07 | 4.09M shares 10-Q · filed 2025-11-07 | 3.28M shares derived: average of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | 4.17M shares 10-Q · filed 2025-08-08 | 4.03M shares 10-Q · filed 2025-08-08 | 2.97M shares derived: average of 3 quarters · filed 2025-08-08 | 2.42M shares derived: average of 4 quarters · filed 2025-08-08 | ||||
| 2024-03-31 | 3.89M shares 10-Q · filed 2025-05-09 | 35.03M shares 10-Q · filed 2024-05-10 | 2.36M shares derived: average of 2 quarters · filed 2025-05-09 | 1.84M shares derived: average of 3 quarters · filed 2025-05-09 | 1.47M shares derived: average of 4 quarters · filed 2025-05-09 | |||
| 2023-12-31 | 835.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 812.81K shares derived: average of 2 quarters · filed 2025-03-25 | 663.72K shares derived: average of 3 quarters · filed 2025-03-25 | 538.01K shares 10-K · filed 2025-03-25 | 4.84M shares 10-K · filed 2024-03-25 | |||
| 2023-09-30 | 789.66K shares 10-Q · filed 2024-11-08 | 7.11M shares 10-Q · filed 2023-11-09 | 577.59K shares derived: average of 2 quarters · filed 2024-11-08 | 438.69K shares 10-Q · filed 2024-11-08 | 3.95M shares 10-Q · filed 2023-11-09 | 1.11M shares derived: average of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | 365.53K shares 10-Q · filed 2024-08-09 | 3.29M shares 10-Q · filed 2023-08-08 | 286.73K shares 10-Q · filed 2024-08-09 | 2.58M shares 10-Q · filed 2023-08-08 | 1.22M shares derived: average of 3 quarters · filed 2024-08-09 | 1.12M shares derived: average of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | 1.86M shares 10-Q · filed 2024-05-10 | 1.64M shares derived: average of 2 quarters · filed 2024-05-10 | 1.38M shares derived: average of 3 quarters · filed 2024-05-10 | 4.30M shares derived: average of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | 1.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 1.14M shares derived: average of 2 quarters · filed 2024-03-25 | 5.11M shares derived: average of 3 quarters · filed 2024-03-25 | 732.30K shares 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | 848.53K shares 10-Q · filed 2023-11-09 | 6.96M shares derived: average of 2 quarters · filed 2023-11-09 | 502.44K shares 10-Q · filed 2023-11-09 | 3.64M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 13.07M shares 10-Q · filed 2023-08-08 | 13.06M shares 10-Q · filed 2023-08-08 | 4.57M shares derived: average of 3 quarters · filed 2023-08-08 | 3.49M shares derived: average of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | 316.38K shares 10-Q · filed 2023-05-09 | 13.06M shares 10-Q · filed 2022-07-08 | 321.47K shares derived: average of 2 quarters · filed 2023-05-09 | 303.51K shares derived: average of 3 quarters · filed 2023-05-09 | 2.09M shares derived: average of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | 326.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 297.08K shares derived: average of 2 quarters · filed 2023-03-23 | 2.69M shares derived: average of 3 quarters · filed 2023-03-23 | 241.10K shares 10-K · filed 2023-03-23 | 9.24M shares 10-K · filed 2022-04-15 | |||
| 2021-09-30 | 267.59K shares 10-Q · filed 2022-11-09 | 10.27M shares 10-Q · filed 2021-11-15 | 3.87M shares derived: average of 2 quarters · filed 2022-11-09 | 212.61K shares 10-Q · filed 2022-11-09 | 8.10M shares 10-Q · filed 2021-11-15 | 4.96M shares derived: average of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | 7.47M shares 10-Q · filed 2022-08-12 | 7.41M shares 10-Q · filed 2022-08-12 | 6.53M shares derived: average of 3 quarters · filed 2022-08-12 | 6.03M shares derived: average of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | 7.36M shares 10-Q · filed 2022-07-08 | 6.06M shares derived: average of 2 quarters · filed 2022-07-08 | 5.55M shares derived: average of 3 quarters · filed 2022-07-08 | |||||
| 2020-12-31 | 4.76M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-07 | 4.65M shares derived: average of 2 quarters · filed 2022-07-07 | 4.59M shares 10-K/A · filed 2022-07-07 | 4.58M shares 10-K · filed 2022-04-15 | ||||
| 2020-09-30 | 4.55M shares 10-Q · filed 2021-11-15 | 4.54M shares 10-Q · filed 2021-11-15 | ||||||
| 2020-03-31 | 4.52M shares 10-Q · filed 2020-05-06 | |||||||
| 2019-03-31 | 4.50M shares 10-Q · filed 2020-05-06 | 67.44M shares 10-Q · filed 2019-05-08 | ||||||
| 2018-03-31 | 17.26M shares 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |